Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1686509

registered interest
date	31/01/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Radicalism
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 23 January (HL1524), under what circumstances (1) a human rights, social justice, or environmental activist, and (2) an individual expressing socialist views, crosses the threshold for Prevent referrals as ‘left wing extremist’; and whether such an individual needs to be planning, involved in or threatening acts of violence in order to be so considered.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL2084
answer	answer is ministerial correction date of answer 15/02/2024 answer text <p>Frontline professionals, when deciding whether to make a referral, should consider whether they believe the person they are concerned about may be on a pathway that could lead to terrorism. In determining whether a concern meets the threshold for referral to Prevent, it is important to consider the harm posed to the person, as well as whether accessing support through Prevent might stop potential wider societal harm committed by the person. A risk-based approach should always be followed, using professional judgement and curiosity. There is no single model of a person’s radicalisation journey or single profile of a radicalised person. There may be times when the precise ideological driver is not clear. Yet, like any safeguarding mechanism, it is far better to receive referrals which turn out not to be of concern than for someone who genuinely needs support to be missed.</p> answering member printed Lord Sharpe of Epsom question first answered 15/02/2024 10:48:07 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1683555

registered interest
date	18/01/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Home Office: Written Questions
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 20 December 2023 (HL1279), whether they will now answer the question put; namely, what steps they are taking to inform parliamentarians about the two reports cited in the original question.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1741
answer	answer is ministerial correction date of answer 01/02/2024 answer text <p>As set out by the response to Written Answer HL767 and HL1279, the Advisory Council on the Misuse of Drugs (ACMD) marked the document titled “Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016” “in confidence”. The Government has no plans to publish the document. The current Working Protocol between the Home Secretary and the Advisory Council on the Misuse of Drugs<strong>, </strong>referred to in the response to question HL1279 is available on gov.uk at the following link: <a href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fworking-protocol-between-the-home-secretary-and-the-advisory-council-on-the-misuse-of-drugs&amp;data=05%7C02%7CLiam.Price2%40homeoffice.gov.uk%7Cb82ba156fbab41f7502b08dc18f0df0c%7Cf24d93ecb2914192a08af182245945c2%7C0%7C0%7C638412670008246154%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=QUBuckFvjvzeA5uv%2FwwArNPNe9l6hzWpiigk90vhxJg%3D&amp;reserved=0" target="_blank">Working Protocol between the Home Secretary and the Advisory Council on the Misuse of Drugs - GOV.UK (www.gov.uk)</a></p> answering member printed Lord Sharpe of Epsom question first answered 01/02/2024 15:25:18 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1683556

registered interest
date	18/01/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Advisory Council on the Misuse of Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 20 December 2023 (HL1278), on what basis the Advisory Council on the Misuse of Drugs (ACMD) marked its report Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016 "in confidence" and did not publish it, given that the working protocol between the Home Secretary and the ACMD states that "The ACMD will publish its advice concurrent with its presentation to Ministers, unless there are pressing public or health protection reasons, or other reasons, for not doing so."
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1742
answer	answer is ministerial correction date of answer 01/02/2024 answer text <p>As the ACMD is an independent Non-Departmental Public Body (NDPB), sponsored by the Home Office, the basis for publication of its reports is a matter for the ACMD.</p> answering member printed Lord Sharpe of Epsom question first answered 01/02/2024 17:44:22 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1681727

registered interest
date	11/01/2024
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Radicalism
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what guidance they are providing for Prevent practitioners on the circumstances under which they are required to refer an individual involved in human rights, social justice or environmental activism who is not expressing support for violence.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1524
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Prevent practitioners should follow the <a href="https://www.gov.uk/government/publications/prevent-duty-guidance" target="_blank">Prevent duty guidance</a>. Free training is available on gov.uk which includes the notice, check, share procedure. Practitioners should consider whether they believe the person may be on a pathway that could lead to terrorism. Those with specific Prevent responsibilities are expected to have a good understanding of extremist ideologies as a key driver of radicalisation and should complete any required ideology training.</p> answering member printed Lord Sharpe of Epsom question first answered 23/01/2024 17:31:08 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1678712

registered interest
date	18/12/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 14 December (HL767), on what basis the Advisory Council for the Misuse of Drugs report Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016, sent to the Home Secretary in December 2016, was shared "in confidence"; and who took the decision to waive any such confidentiality in relation to the part of the report that has been made public.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1278
answer	answer is ministerial correction date of answer 20/12/2023 answer text <p>As set out by the response to Written Answer HL767, the Advisory Council on the Misuse of Drugs (ACMD) marked the document titled “Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016” “in confidence”. The document was not intended for publication and there are no plans to publish it. The portion that has been made public was made public under the terms of the Freedom of Information Act 2000 (“FOIA 2000”) and following the decision of the relevant tribunal (case reference EA/2021/0301).</p><p> </p><p>The portion released under the FOIA 2000 recommended a review of the Working Protocol between the ACMD and the Home Office to take into account the functions of the ACMD under the Psychoactive Substances Act 2016 (“the 2016 Act”). The Working Protocol has not been revised since 2011 and is available at the following link: <a href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fworking-protocol-between-the-home-secretary-and-the-advisory-council-on-the-misuse-of-drugs&amp;data=05%7C02%7CLiam.Price2%40homeoffice.gov.uk%7C0f3b5e5094924fd41a1f08dc007d513b%7Cf24d93ecb2914192a08af182245945c2%7C0%7C0%7C638385785729643796%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=XnT9RCvi7TX1aQJ07uHM7aufQZsu5b94e9Vwc0EZ1H4%3D&amp;reserved=0" target="_blank">Working Protocol between the Home Secretary and the Advisory Council on the Misuse of Drugs - GOV.UK (www.gov.uk)</a></p><p> </p><p>The Government intends to undertake a review in due course and if this results in a revised Working Protocol, the revised version will be published on gov.uk.</p> answering member printed Lord Sharpe of Epsom grouped question UIN HL1279 HL1280 question first answered 20/12/2023 16:45:20 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1678713

registered interest
date	18/12/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 14 December (HL767), what steps they have taken to ensure that parliamentarians are properly informed about the issues raised in the Advisory Council for the Misuse of Drugs report Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016, sent to the Home Secretary in December 2016.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1279
answer	answer is ministerial correction date of answer 20/12/2023 answer text <p>As set out by the response to Written Answer HL767, the Advisory Council on the Misuse of Drugs (ACMD) marked the document titled “Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016” “in confidence”. The document was not intended for publication and there are no plans to publish it. The portion that has been made public was made public under the terms of the Freedom of Information Act 2000 (“FOIA 2000”) and following the decision of the relevant tribunal (case reference EA/2021/0301).</p><p> </p><p>The portion released under the FOIA 2000 recommended a review of the Working Protocol between the ACMD and the Home Office to take into account the functions of the ACMD under the Psychoactive Substances Act 2016 (“the 2016 Act”). The Working Protocol has not been revised since 2011 and is available at the following link: <a href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fworking-protocol-between-the-home-secretary-and-the-advisory-council-on-the-misuse-of-drugs&amp;data=05%7C02%7CLiam.Price2%40homeoffice.gov.uk%7C0f3b5e5094924fd41a1f08dc007d513b%7Cf24d93ecb2914192a08af182245945c2%7C0%7C0%7C638385785729643796%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=XnT9RCvi7TX1aQJ07uHM7aufQZsu5b94e9Vwc0EZ1H4%3D&amp;reserved=0" target="_blank">Working Protocol between the Home Secretary and the Advisory Council on the Misuse of Drugs - GOV.UK (www.gov.uk)</a></p><p> </p><p>The Government intends to undertake a review in due course and if this results in a revised Working Protocol, the revised version will be published on gov.uk.</p> answering member printed Lord Sharpe of Epsom grouped question UIN HL1278 HL1280 question first answered 20/12/2023 16:45:20 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1678714

registered interest
date	18/12/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Advisory Council on the Misuse of Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Sharpe of Epsom on 14 December (HL767), what is the status of the review of the Working Protocol between the Advisory Council for the Misuse of Drugs and the Home Office; when the review will be completed; and whether it will be published.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1280
answer	answer is ministerial correction date of answer 20/12/2023 answer text <p>As set out by the response to Written Answer HL767, the Advisory Council on the Misuse of Drugs (ACMD) marked the document titled “Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016” “in confidence”. The document was not intended for publication and there are no plans to publish it. The portion that has been made public was made public under the terms of the Freedom of Information Act 2000 (“FOIA 2000”) and following the decision of the relevant tribunal (case reference EA/2021/0301).</p><p> </p><p>The portion released under the FOIA 2000 recommended a review of the Working Protocol between the ACMD and the Home Office to take into account the functions of the ACMD under the Psychoactive Substances Act 2016 (“the 2016 Act”). The Working Protocol has not been revised since 2011 and is available at the following link: <a href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fworking-protocol-between-the-home-secretary-and-the-advisory-council-on-the-misuse-of-drugs&amp;data=05%7C02%7CLiam.Price2%40homeoffice.gov.uk%7C0f3b5e5094924fd41a1f08dc007d513b%7Cf24d93ecb2914192a08af182245945c2%7C0%7C0%7C638385785729643796%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=XnT9RCvi7TX1aQJ07uHM7aufQZsu5b94e9Vwc0EZ1H4%3D&amp;reserved=0" target="_blank">Working Protocol between the Home Secretary and the Advisory Council on the Misuse of Drugs - GOV.UK (www.gov.uk)</a></p><p> </p><p>The Government intends to undertake a review in due course and if this results in a revised Working Protocol, the revised version will be published on gov.uk.</p> answering member printed Lord Sharpe of Epsom grouped question UIN HL1278 HL1279 question first answered 20/12/2023 16:45:20 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1678715

registered interest
date	18/12/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they made of the effectiveness of overdose prevention centres in reducing death and other harms caused by drug use to individuals and society; and why they do not support pilot overdose prevention centres.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL1281
answer	answer is ministerial correction date of answer 11/01/2024 answer text <p>The Government does not support drug consumption rooms. We have been clear that we have concerns about the potential for these facilities to appear to condone drug use and to encourage the continued illicit supply of drugs. They will not be introduced in England and Wales.</p><p> </p><p>We are aware of previous international studies of DCRs, sometimes referred to as overdose prevention centres, although there is usually little or no focus on how far DCRs reduce illicit drug use by those using DCRs, or whether they result in reductions in overall drug use. Methodological and geographical differences as well as the small number of cities where DCRs operate makes it difficult to draw firm conclusions at this stage. In addition, the impact of DCRs in isolation is hard to measure as a range of other support and interventions such as needle and syringe exchange programmes are often provided within a DCR.</p><p> </p> answering member printed Lord Sharpe of Epsom question first answered 11/01/2024 14:21:25 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1674522

registered interest
date	30/11/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what policy changes they are actively considering, formulating and developing in relation to the Advisory Council for the Misuse of Drugs report sent to the Home Secretary in December 2016, titled Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016; and when they expect this policy process to conclude.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL767
answer	answer is ministerial correction date of answer 14/12/2023 answer text <p>The Psychoactive Substances Act 2016 (PSA) was designed to complement the Misuse of Drugs Act 1971 (MDA), by introducing civil sanctions and offences for those who produce, possess with intent to supply, supply, offer to supply and import or export new psychoactive substances which are not controlled under the MDA or which are not otherwise exempt. One of the important safeguards which the PSA provides is ensuring there are no gaps in law enforcement powers to tackle newly emerging harmful drugs. This is in the context that prior to 2016 criminal gangs were designing new psychoactive drugs with different chemical structures in order to evade MDA controls. Substances can be moved into the MDA following advice on their harms from the Advisory Council on the Misuse of Drugs (ACMD) and subject to the decisions of Ministers.</p><p>A review of the PSA published in 2018 found that there is no evidence that the PSA has adversely affected the process or timeliness with which substances can be controlled under the MDA, with substances continuing to be controlled after the Act was introduced. <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/756896/Review_of_the_Psychoactive_Substances_Act__2016___web_.pdf" target="_blank">Review of the Psychoactive Substances Act 2016 (publishing.service.gov.uk)</a>. The government keeps all legislation under review, but has no plans to change either legislative regime substantially.</p><p>The report referred to as ‘Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016’ was shared with the Home Office in confidence by the ACMD and is not a public document. One recommendation has been made public, concerning a review of the Working Protocol between the ACMD and the Home Office, which the government has agreed to undertake.</p><p> </p> answering member printed Lord Sharpe of Epsom grouped question UIN HL768 question first answered 14/12/2023 17:36:11 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb

1674523

registered interest
date	30/11/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Drugs: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016, and what plans they have to harmonise those two regimes.
tabling member printed	Baroness Jones of Moulsecoomb
uin	HL768
answer	answer is ministerial correction date of answer 14/12/2023 answer text <p>The Psychoactive Substances Act 2016 (PSA) was designed to complement the Misuse of Drugs Act 1971 (MDA), by introducing civil sanctions and offences for those who produce, possess with intent to supply, supply, offer to supply and import or export new psychoactive substances which are not controlled under the MDA or which are not otherwise exempt. One of the important safeguards which the PSA provides is ensuring there are no gaps in law enforcement powers to tackle newly emerging harmful drugs. This is in the context that prior to 2016 criminal gangs were designing new psychoactive drugs with different chemical structures in order to evade MDA controls. Substances can be moved into the MDA following advice on their harms from the Advisory Council on the Misuse of Drugs (ACMD) and subject to the decisions of Ministers.</p><p>A review of the PSA published in 2018 found that there is no evidence that the PSA has adversely affected the process or timeliness with which substances can be controlled under the MDA, with substances continuing to be controlled after the Act was introduced. <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/756896/Review_of_the_Psychoactive_Substances_Act__2016___web_.pdf" target="_blank">Review of the Psychoactive Substances Act 2016 (publishing.service.gov.uk)</a>. The government keeps all legislation under review, but has no plans to change either legislative regime substantially.</p><p>The report referred to as ‘Interaction and relationship between the Misuse of Drugs Act 1971 and the Psychoactive Substances Act 2016’ was shared with the Home Office in confidence by the ACMD and is not a public document. One recommendation has been made public, concerning a review of the Working Protocol between the ACMD and the Home Office, which the government has agreed to undertake.</p><p> </p> answering member printed Lord Sharpe of Epsom grouped question UIN HL767 question first answered 14/12/2023 17:36:11 answering member 4888 label Biography information for Lord Sharpe of Epsom
tabling member	4297 label Biography information for Baroness Jones of Moulsecoomb